The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gliofocus: A global, open-label, randomized phase 3 study comparing niraparib with temozolomide in newly diagnosed MGMT-unmethylated glioblastoma.
 
Nader Sanai
Employment - Barrow Neurological Institute
Research Funding - The Ben & Catherine Ivy Foundation (Inst)
 
Shwetal Mehta
Patents, Royalties, Other Intellectual Property - Listed as co-inventor on this patent - Use of niraparib for the treatment of brain cancer. WO2023159066A1
 
Artak Tovmasyan
Patents, Royalties, Other Intellectual Property - A patent that I co-authored was licensed by Duke University to BioMimetix JV, LLC, which currently tests a molecule in clinical trials.
 
Jocelyn Harmon
Employment - Dignity Health
Travel, Accommodations, Expenses - Dignity Health
 
William Kennedy
No Relationships to Disclose
 
Anthony Chalmers
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca; Bristol-Myers Squibb; Duke Street Bio
 
Mustafa Khasraw
Stock and Other Ownership Interests - siren
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; George Clincal; Janssen; Lilly; Novocure; Roche; SERVIER; Stemline Therapeutics; Voyager Therapeutics
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); cns pharmaceuticals (Inst); daiichi Sankyo (Inst); Immorna (Inst); Immvira (Inst); Personalis (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Mary Jane Lim-Fat
Honoraria - Novocure; SERVIER
Consulting or Advisory Role - Canadian Agency for Drugs and Technologies in Health (CADTH); Cancer Care Ontario
 
Giuseppe Minniti
Consulting or Advisory Role - AstraZeneca; Novocure; Pfizer; SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Juan Manuel Sepulveda Sanchez
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Bristol-Myers Squibb; Cantex Pharmaceuticals; CeCaVa; Novocure; SERVIER
Speakers' Bureau - Cantex Pharmaceuticals; SERVIER
Research Funding - IDP Pharmaceuticals; Pfizer; Tilray
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Mehdi Touat
Consulting or Advisory Role - Agios; GlaxoSmithKline; Integragen; NH TherAguix; Novocure; SERVIER; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; SERVIER
 
Yoshie Umemura
Consulting or Advisory Role - SERVIER
Speakers' Bureau - SERVIER
Research Funding - Curis; GlaxoSmithKline; Jazz Pharmaceuticals; Nuvation Bio